419 related articles for article (PubMed ID: 33506055)
21. Natural Killer T Cells and Mucosal-Associated Invariant T Cells in Lung Infections.
Trottein F; Paget C
Front Immunol; 2018; 9():1750. PubMed ID: 30116242
[TBL] [Abstract][Full Text] [Related]
22. Human invariant natural killer T cells: implications for immunotherapy.
Takahashi T; Kurokawa M
Int J Hematol; 2009 Sep; 90(2):137-142. PubMed ID: 19639273
[TBL] [Abstract][Full Text] [Related]
23. Aging unconventionally: γδ T cells, iNKT cells, and MAIT cells in aging.
Kurioka A; Klenerman P
Semin Immunol; 2023 Sep; 69():101816. PubMed ID: 37536148
[TBL] [Abstract][Full Text] [Related]
24. Invariant natural killer T cells and mucosal-associated invariant T cells in multiple sclerosis.
Bianchini E; De Biasi S; Simone AM; Ferraro D; Sola P; Cossarizza A; Pinti M
Immunol Lett; 2017 Mar; 183():1-7. PubMed ID: 28119072
[TBL] [Abstract][Full Text] [Related]
25. The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting.
Li Y; Li G; Zhang J; Wu X; Chen X
Front Immunol; 2020; 11():619954. PubMed ID: 33664732
[TBL] [Abstract][Full Text] [Related]
26. Expansion of MAIT cells in the combined absence of NKT and γδ-T cells.
Xu C; Li S; Fulford TS; Christo SN; Mackay LK; Gray DH; Uldrich AP; Pellicci DG; I Godfrey D; Koay HF
Mucosal Immunol; 2023 Aug; 16(4):446-461. PubMed ID: 37182737
[TBL] [Abstract][Full Text] [Related]
27. Early-life imprinting of unconventional T cells and tissue homeostasis.
Constantinides MG; Belkaid Y
Science; 2021 Dec; 374(6573):eabf0095. PubMed ID: 34882451
[TBL] [Abstract][Full Text] [Related]
28. Regulation and Functions of Protumoral Unconventional T Cells in Solid Tumors.
Barsac E; de Amat Herbozo C; Gonzalez L; Baranek T; Mallevaey T; Paget C
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298791
[TBL] [Abstract][Full Text] [Related]
29. Antileukemia and antitumor effects of the graft-versus-host disease: a new immunovirological approach.
Sinkovics JG
Acta Microbiol Immunol Hung; 2010 Dec; 57(4):253-347. PubMed ID: 21183421
[TBL] [Abstract][Full Text] [Related]
30. MR1-restricted T cells: the new dawn of cancer immunotherapy.
Wang Z; Wang M; Chen J; Zhang L; Zhang L; Yu L
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185693
[TBL] [Abstract][Full Text] [Related]
31. On the use of donor-derived iNKT cells for adoptive immunotherapy to prevent leukemia recurrence in pediatric recipients of HLA haploidentical HSCT for hematological malignancies.
Dellabona P; Casorati G; de Lalla C; Montagna D; Locatelli F
Clin Immunol; 2011 Aug; 140(2):152-9. PubMed ID: 21185785
[TBL] [Abstract][Full Text] [Related]
32. Biased MAIT TCR Usage Poised for Limited Antigen Diversity?
Souter MNT; Eckle SBG
Front Immunol; 2020; 11():1845. PubMed ID: 33013835
[TBL] [Abstract][Full Text] [Related]
33. MAIT cell-mediated cytotoxicity: Roles in host defense and therapeutic potentials in infectious diseases and cancer.
Rudak PT; Choi J; Haeryfar SMM
J Leukoc Biol; 2018 Sep; 104(3):473-486. PubMed ID: 29668066
[TBL] [Abstract][Full Text] [Related]
34. Characterization of Human Mucosal-associated Invariant T (MAIT) Cells.
Souter MNT; Loh L; Li S; Meehan BS; Gherardin NA; Godfrey DI; Rossjohn J; Fairlie DP; Kedzierska K; Pellicci DG; Chen Z; Kjer-Nielsen L; Corbett AJ; McCluskey J; Eckle SBG
Curr Protoc Immunol; 2019 Dec; 127(1):e90. PubMed ID: 31763790
[TBL] [Abstract][Full Text] [Related]
35. Human γδ T-Cells: From Surface Receptors to the Therapy of High-Risk Leukemias.
Pistoia V; Tumino N; Vacca P; Veneziani I; Moretta A; Locatelli F; Moretta L
Front Immunol; 2018; 9():984. PubMed ID: 29867961
[TBL] [Abstract][Full Text] [Related]
36. Antigen-Presenting Cell Characteristics of Human γδ T Lymphocytes in Chronic Myeloid Leukemia.
Sawaisorn P; Tangchaikeeree T; Chan-On W; Leepiyasakulchai C; Udomsangpetch R; Hongeng S; Jangpatarapongsa K
Immunol Invest; 2019 Jan; 48(1):11-26. PubMed ID: 30321079
[TBL] [Abstract][Full Text] [Related]
37. A close look at current γδ T-cell immunotherapy.
Ma L; Feng Y; Zhou Z
Front Immunol; 2023; 14():1140623. PubMed ID: 37063836
[TBL] [Abstract][Full Text] [Related]
38. Deficiencies of Circulating Mucosal-associated Invariant T Cells and Natural Killer T Cells in Patients with Multiple Trauma.
Jo YG; Choi HJ; Kim JC; Cho YN; Kang JH; Jin HM; Kee SJ; Park YW
J Korean Med Sci; 2017 May; 32(5):750-756. PubMed ID: 28378547
[TBL] [Abstract][Full Text] [Related]
39. Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease.
Chang YJ; Zhao XY; Huang XJ
Front Immunol; 2018; 9():3041. PubMed ID: 30619371
[TBL] [Abstract][Full Text] [Related]
40. Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line.
Kang CH; Kim Y; Lee HK; Lee SM; Jeong HG; Choi SU; Park CH
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
